benzyloxycarbonyl-phe-ala-fluormethylketone has been researched along with suramin in 1 studies
Studies (benzyloxycarbonyl-phe-ala-fluormethylketone) | Trials (benzyloxycarbonyl-phe-ala-fluormethylketone) | Recent Studies (post-2010) (benzyloxycarbonyl-phe-ala-fluormethylketone) | Studies (suramin) | Trials (suramin) | Recent Studies (post-2010) (suramin) |
---|---|---|---|---|---|
5 | 0 | 5 | 3,023 | 92 | 431 |
Protein | Taxonomy | benzyloxycarbonyl-phe-ala-fluormethylketone (IC50) | suramin (IC50) |
---|---|---|---|
ATP-dependent 6-phosphofructokinase | Trypanosoma brucei brucei | 3 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 9.76 | |
P2X purinoceptor 2 | Rattus norvegicus (Norway rat) | 4 | |
DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | 1.7 | |
DNA primase | Mycobacterium tuberculosis CDC1551 | 8.2 | |
RmtA | Aspergillus nidulans | 5.9 | |
Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 9.4 | |
NAD-dependent protein deacetylase sirtuin-2 | Homo sapiens (human) | 1.15 | |
NAD-dependent protein deacetylase sirtuin-1 | Homo sapiens (human) | 1.5667 | |
Protein arginine N-methyltransferase 1 | Homo sapiens (human) | 5.33 | |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | 2.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angelo, IC; Conti, P; De Micheli, C; Ettari, R; Micale, N; Pinto, A; Tamborini, L | 1 |
1 other study(ies) available for benzyloxycarbonyl-phe-ala-fluormethylketone and suramin
Article | Year |
---|---|
Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis.
Topics: Cathepsin L; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Protozoan Proteins; Structure-Activity Relationship; Trypanocidal Agents; Trypanosomiasis, African | 2013 |